PMC:7553377 / 12480-12989 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7553377","sourcedb":"PMC","sourceid":"7553377","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7553377","text":"Three (42.8%) patients in the non-progressive group and 11 (55%) patients in the progressive group had comorbidites. Six (85.7%) patients in the non-progressive group and 18 (90%) patients in the progressive group received hydroxychloroquine therapy. Nine (45%) patients in the progressive group had favipiravir treatment while it was started in 1 (14.3%) patient in the non-progressive group. No significant differences of comorbidities and treatment were found between the two groups of patients (p \u003e 0.05).","tracks":[]}